glp-1 long term use Bariatric Surgery vs Medications for Long-Term Weight Loss GLP-1 Agonists: A Comprehensive Overview

39,40 Tirzepatide is currently only TGA approved for type 2 diabetes, and semaglutide-cagrilintide is undergoing clinical trials

Badat, P

Its crucial to note that individuals with diabetes are not eligible for the Bridge program, as diabetes-related treatments should already be covered by existing health plans

While these findings are promising, further research and randomized controlled trials are necessary to confirm their efficacy in treating addiction

Healthcare professionals should maintain awareness of the warnings and precautions and ensure these are reassessed if new family history information emerges

A phase 3 clinical study with a higher dosage of daily 25 and 50 mg of oral semaglutide is about to be initiated, in the hope of obtaining promising data for both body weight reduction and cardiovascular benefits [34,37]